focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,782.50
Bid: 1,782.50
Ask: 1,783.00
Change: -30.00 (-1.66%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,782.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: FTSE bounces off five-month low after late rally

Tue, 16th Jun 2015 17:08

UK stocks managed to claw their way back to finish flat on Tuesday as investors sought out bargains after markets dropped to a five-month intraday low.Stocks in the tobacco, housebuilding and pharmaceutical sectors extended gains late on, while Royal Mail rebounded after earlier weakness, making up for falls in the heavyweight mining and banking sectors.The FTSE 100 ended the day down just 0.42 points (-0.01%) at 6,710.10 after a late afternoon rally across Europe.The rebound followed a decent start on Wall Street after stronger-than-expected housing data, with May US housing permits rising at their fastest rate since 2007.Nevertheless, the Footsie sank to a daily low of 6,656.90 earlier on, a level not seen mid-January, as the Greek debt crisis raged on.An abrupt end to negotiations at the weekend in Brussels with Greece's lenders has rattled investors' nerves over recent days, as discussions collapsed after just 45 minutes on the back of disagreements over issues such as pension reforms and tax rates.Eurozone officials are now considering an emergency summit next weekend amid fears that Athens and its creditors will not reach a deal at a meeting of finance ministers on Thursday."While this does cue up excitement for the end of this week and the beginning of the next, it leaves us no further along the road to a solution," said IG analyst Chris Beauchamp.Defensives gainA reduction in risk appetite benefitted stocks in defensive sectors such as tobacco and pharmaceuticals. British American Tobacco, Imperial Tobacco and Glaxosmithkline all finished higher and managed to hold on to gains despite the wider market rally.British American Tobacco and Imperial Tobacco were boosted after Credit Suisse reinstated coverage on both stocks at 'outperform'. The broker applauded BAT's "consistent track record" and showed optimism about Imperial's recent purchase of Reynolds assets.Meanwhile, GSK was up on rumours it could become the latest takeover target in the industry. According to the Daily Mail, market participants are speculating that the company may face an approach from Switzerland's Roche or US company Johnson & Johnson at about 1900p per share.Housebuilders also performed well, such as Barratt Developments, Taylor Wimpey, Persimmon and Crest Nicholson. Crest Nicholson impressed with an upbeat outlook as it posted a 52% jump in first-half profits.Royal Mail shares bounced into positive territory, erasing earlier losses on concerns about an Ofcom review into the regulation of the postal operator after the withdrawal of rival Whistl. Despite investor concerns, Investec reiterated a 'buy' recommendation on Royal Mail, saying: "We do not expect any substantive changes when the review concludes in 2016."Industrial equipment hire company Ashtead underwhelmed with full-year results. The group posted a 33% rise in full-year pre-tax profit to £473.8m on strong US and UK markets.Market MoverstechMARK 3,153.62 +0.07%FTSE 100 6,710.10 -0.01%FTSE 250 17,736.19 +0.04%FTSE 100 - RisersBritish American Tobacco (BATS) 3,511.00p +2.92%Barratt Developments (BDEV) 609.50p +2.27%Imperial Tobacco Group (IMT) 3,246.00p +2.24%Centrica (CNA) 267.40p +2.06%Taylor Wimpey (TW.) 186.90p +1.91%Persimmon (PSN) 1,959.00p +1.66%Mondi (MNDI) 1,380.00p +1.32%SABMiller (SAB) 3,336.50p +1.12%GlaxoSmithKline (GSK) 1,366.00p +1.11%National Grid (NG.) 858.00p +1.11%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 4,502.00p -2.68%Ashtead Group (AHT) 1,097.00p -2.66%Anglo American (AAL) 972.20p -2.23%Rio Tinto (RIO) 2,745.50p -2.17%Antofagasta (ANTO) 712.50p -2.13%Fresnillo (FRES) 720.00p -1.84%BT Group (BT.A) 445.25p -1.61%Glencore (GLEN) 274.20p -1.46%International Consolidated Airlines Group SA (CDI) (IAG) 502.00p -1.28%ARM Holdings (ARM) 1,089.00p -1.27%FTSE 250 - RisersLadbrokes (LAD) 122.10p +4.36%De La Rue (DLAR) 535.50p +2.78%Man Group (EMG) 164.80p +2.36%Petra Diamonds Ltd.(DI) (PDL) 159.00p +2.32%Fidessa Group (FDSA) 2,255.00p +2.27%Crest Nicholson Holdings (CRST) 556.00p +2.11%Ted Baker (TED) 2,906.00p +2.07%Atkins (WS) (ATK) 1,532.00p +1.79%Computacenter (CCC) 730.00p +1.74%National Express Group (NEX) 313.50p +1.69%FTSE 250 - FallersKaz Minerals (KAZ) 232.00p -4.92%Centamin (DI) (CEY) 61.65p -3.52%Allied Minds (ALM) 545.00p -2.94%Lonmin (LMI) 127.00p -2.08%Tullow Oil (TLW) 362.00p -2.00%Petrofac Ltd. (PFC) 882.50p -2.00%Vedanta Resources (VED) 582.00p -1.94%Cairn Energy (CNE) 181.10p -1.90%Wood Group (John) (WG.) 674.00p -1.89%Rathbone Brothers (RAT) 2,178.00p -1.80%
More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.